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Abstract
Objectives: Surgical excision is the standard strategy for managing liver metastases from colorectal
carcinoma. The achievement of negative (R0) margins is a major determinant of disease-free survival in
these patients. Current imaging techniques are of limited value in achieving this goal. A new approach to
the intraoperative detection of colorectal liver metastatic tissue based on the emission of indocyanine
green (ICG) fluorescence was evaluated.
Methods: A total of 25 consecutive patients with liver metastases from primary colorectal cancers who
were eligible for liver resection received a bolus of ICG (0.5 mg/kg body weight) 24 h before surgery.
During surgery, ICG fluorescence, which accumulates around lesions as a result of defective biliary
clearance, was detected with a near-infrared camera system, the Photodynamic Eye (PDE). Numbers of
lesions detected by, respectively, PDE + ICG, intraoperative ultrasound (IOUS) and preoperative com-
puted tomography (CT) were recorded.
Results: The near-infrared camera plus ICG revealed a total of 77 metastatic liver nodules. Preoperative
CT demonstrated 45 (58.4%) and IOUS showed 55 (71.4%). Preoperative CT and IOUS alone were
inferior to the combined use of PDE + ICG and IOUS in the detection of lesions of 3 mm in size.
Conclusions: This experience suggests that PDE + ICG, combined with IOUS, may represent a safe and
effective tool for ensuring the complete surgical eradication of liver metastases from colorectal cancer.
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Introduction
Colorectal carcinoma (CRC) is one of the most commonly occur-
ring tumours throughout the world.1 The prognosis in CRC has
improved, mainly as a result of the integrated use of oncological
and surgical therapies, but the development of liver metastases is
still a frequent event in the natural history of the disease.2,3 In a
significant percentage of patients, the liver is the sole site of seed-
ing.3,4 The development and progression of hepatic metastases
have been widely studied in the field of surgery.5 Left untreated,
these lesions are associated with a median survival of about 5
months.3–5 In the 1980s, Adson and van Heerden demonstrated
that liver metastases could be potentially cured by liver resection,6
and subsequently surgery became the reference-standard treat-
ment for these lesions.7 However, although surgery did appear to
offer the best chance of cure, only about 20% of patients with liver
metastases were eligible for resection.8 The percentage is not much
higher today, although recent studies show that resectability rates
can be increased with the use of new technologies, drugs and
surgical procedures.9–13 The contraindications for liver resection
defined in the 1980s are no longer valid: patients with more than
three metastatic nodules or nodules of >5 cm in diameter can now
be safely treated with surgical resection. Recent studies indicate
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that liver surgery, including extensive resection, is associated with
mortality rates of 1–2%.14 Survival rates have also improved and
several large studies have shown disease-free survival rates of
around 45%.15–22
There is widespread agreement that one single variable has a
very significant impact on survival in this setting: the achievement
of negative (R0) resection margins.23–26 This requires the complete
removal of all tumour so that microscopic examination of the
margins shows no neoplastic cells. The presence of residual foci of
tumour cells, whether they are macroscopic or microscopic, is
associated with tumour recurrence and lower survival rates.24 The
importance of radical tumour removal is undeniable, although
the optimal dimensions of the tumour-free margin are still a topic
of debate.24
This is a complicated problem because small nodules can be
located at varying distances from larger metastatic lesions, and the
resolution offered by current imaging techniques may not be suf-
ficient to detect them. Computed tomography (CT), magnetic
resonance imaging and ultrasonography (US) are the mainstays of
liver tumour detection and staging.27,28 All have a high degree of
accuracy and the preoperative use of these imaging techniques is
useful in planning a liver resection. However, they can easily miss
lesions with diameters of  3 mm and they provide still pictures
only, which are of limited value as a navigation tool.
Intraoperative US (IOUS) is currently regarded as the
reference-standard method of guiding liver resection. It offers
the undeniable advantage of real-time visualization, but it also
has several shortcomings: (i) it cannot detect lesions of  3 mm
in size; (ii) its accuracy is highly dependent on the skill and
experience of the operator; (iii) the images it provides are two-
rather than three-dimensional, and (iv) there is a superficial
blind area about 1 cm under the liver surface, which is especially
problematic in colorectal liver metastases as these are mostly
located on the surface of the liver parenchyma. The introduction
of acoustic contrast enhancement is an appealing evolution,
but the contrast effect is too short-lived to be of real value as a
navigation tool during standard liver resection, which can take
2–6 h.
Recently, a new approach based on the emission of indocyanine
green (ICG) fluorescence has been used to improve the intraop-
erative detection of neoplastic tissue.29,30 The aim of the present
study was to test the hypothesis that this system could be used
synergistically with IOUS to detect metastatic liver lesions in
patients with CRC. Previous studies have shown that the com-
bined use of both techniques can overcome the limitations of each
and identify a substantial number of lesions that are not revealed
by IOUS alone.29
Materials and methods
Patient characteristics
From August 2011 to June 2012, 25 patients (Table 1) with liver
metastases from primary CRC were enrolled at the IRCCS (Isti-
tuto di Recovero e Cura a Carattere Scientifico) San Matteo
General Hospital in Pavia. All had been previously evaluated by
the hospital’s multidisciplinary liver team and deemed eligible for
resection with curative intent. The decisions were based on
imaging findings (multidetector-row CT and contrast-enhanced
US) and histological examination of US-guided percutaneous
biopsies of a sample liver lesion. Patients were excluded if
enrolment interviews revealed evidence of allergies to iodine or
ICG. Written informed consent was obtained from each study
participant.
Administration of ICG and fluorescence imaging
At 24 h prior to surgery, each patient was given an i.v. dose of ICG
(0.5 mg/kg body weight).After 24 h, normal liver parenchyma will
have washed out most of the ICG. The dye is retained as a fluo-
rescent rim that is found in stromal tissue in the transition area
between tumour and normal liver tissue in all liver metastases.
During surgery, such fluorescence was detected with a near-
infrared (NIR) camera system, the Photodynamic Eye (PDE)
(Hamamatsu Photonics KK, Hamamatsu, Japan), which activates
the ICG fluorescence with a series of diodes that emit light at a
wavelength of 760 nm while cutting off emissions below 820 nm.
The emissions are detected with a charge-coupled device. For
intraoperative use, the unit was wrapped in a disposable, sterile
drape, and the real-time video output of the system was displayed
on a monitor next to that of the US scanner.
Surgical procedure and intraoperative
lesion detection
After standard transverse laparotomy, the liver was freed from the
surrounding tissues by dissection of the ligaments and vena cava.
The liver hilum was dissected and circled with a tape for an even-
tual Pringle manoeuvre. The surgeon then performed a standard
IOUS examination and PDE assessment of ICG fluorescence
(PDE + ICG). The surgical procedure was then performed under
dual US and PDE guidance. The parenchyma was dissected using
a Cavitron ultrasonic surgical aspirator and the Kelly clamp crush
technique. The resection planes were examined with IOUS and
PDE + ICG during and after resection to ensure that there was no
residual neoplastic tissue. Blood vessels and bile ducts of >5 mm
Table 1 Characteristics of patients included in the study (n = 25)
Patient characteristics
Age, years, median (range) 61.5 (42–87)
Gender, n Male 17
Female 8
Preoperative
chemotherapy, n
Yes 13
No 12
Lesions (n = 78)
Synchronous 38
Metachronous 40
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in diameter were ligated; smaller vessels were sealed with a har-
monic scalpel.
Evaluation of imaging
In each case, preoperative and intraoperative imaging data were
subjected to post hoc review (Fig. 1). For each method used (CT,
IOUS and PDE + ICG fluorescence), the total number of nodules
detected was recorded, as were the numbers of nodules that were
>3 mm or 3 mm in diameter (a diameter of 3 mm is commonly
regarded as a reasonable detection threshold in both CT and US).
Statistical analysis
Data were analysed using GraphPad Prism Version 6.00 for OsX
(GraphPad Software, Inc., La Jolla, CA, USA). Differences were
assessed with Kruskal–Wallis non-parametric analysis of variance
(anova) and Dunn’s multiple comparisons test. A P-value of
<0.05 was considered to indicate statistical significance.
Results
Outcome of surgery
All patients recovered satisfactorily from surgery and had
uneventful postoperative courses. As expected, transient altera-
tions were observed in liver function parameters, but in all cases
values returned to the preoperative baseline range by postopera-
tive day 3. Postoperative complications included pleural effusion,
fever and a slight delay in the return of bowel function. Mean 
standard deviation intraoperative blood loss was 300  200 ml.
Mean hospital stay was 6 days.
Detection of metastatic liver nodules
Figure 2 reports the findings of this study. After the postoperative
histopathological examination, one of the lesions identified only
by PDE + ICG was considered benign. Only one malignant lesion
showed positive microscopic resection margins.
The use of concomitant IOUS and PDE significantly improved
the detection of liver metastases in comparison with preoperative
(a)
(c)
(b)
Figure 1 In computed tomography (a) and intraoperative ultrasound (b), findings appear to be unremarkable. (c) Near-infrared imaging using
the Photodynamic Eye demonstrates a nodule
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CT (P = 0.0029). The use of IOUS alone, however, did not improve
detection significantly in comparison with preoperative CT (P =
0.3905) (Fig. 3).
The lesions identified were divided into two groups according
to size, consisting of lesions of >3 mm and lesions of 3 mm in
diameter.
No differences emerged between preoperative CT, IOUS and
IOUS + PDE in the detection of lesions of >3 mm (P > 0.9999)
(Fig. 4). Intraoperative US is limited to the detection of lesions of
>3 mm in size.
Differences among the three imaging methods emerged in the
detection of lesions of3 mm. The use of concomitant IOUS and
PDE was most successful, detecting 29 lesions in comparison with
15 detected by IOUS alone (IOUS mean rank: 33.88; IOUS + PDE
mean rank: 46.48; P = 0.0328) and nine detected by preoperative
CT alone (CT mean rank: 22.00; IOUS + PDE mean rank: 46.48;
P < 0.0001) There was no significant difference in numbers
detected between CT and IOUS (CT mean rank: 22.00; IOUS
mean rank: 33.88; P = 0.0708) (Fig. 5).
Discussion
The present study provides preliminary clinical evidence indicat-
ing that the intraoperative detection of liver metastases, particu-
larly of very small lesions, which are frequently missed with
45 lesions identified by CT
10 additional lesions identified
by IOUS
Total lesions = 55
23 additional lesions identified
by PDE + ICG
Total lesions = 78
Metastases/other: 45/0
Metastases/other: 55/0
Metastases/other: 77/1
37 lesions > 3mm
40 lesions > 3mm
8 lesions ≤ 3mm
15 lesions ≤ 3mm
49 lesions > 3mm
29 lesions ≤ 3mm
Figure 2 Stratification of findings among the cases. Only one event
was deemed a false positive. CT, computed tomography; IOUS, intra-
operative ultrasound; PDE, Photodynamic Eye; ICG, indocyanine green
Figure 3 Overall evaluation of all observed nodules. CT, computed tomography; IOUS, intraoperative ultrasound; PDE, Photodynamic Eye;
NS, not significant
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Figure 4 Stratification of the nodules by size shows no difference in findings of tumours of >3 mm. CT, computed tomography;
IOUS, intraoperative ultrasound; PDE, Photodynamic Eye; NS, not significant
Figure 5 Stratification of the nodules by size shows that the combined use of intraoperative ultrasound and the Photodynamic Eye allows
a significant advantage in the detection of nodules of 3 mm. CT, computed tomography; IOUS, intraoperative ultrasound;
PDE, Photodynamic Eye; NS, not significant
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conventional imaging modalities, can be substantially improved
with the use of ICG fluorescence detection (Fig. 6). The PDE +
ICG system provides detailed, real-time video imaging that serves
as an excellent guide throughout the liver resection procedure.
This approach can be used alone or in combination with tradi-
tional IOUS, thereby exploiting the strong points of each method:
US provides high sensitivity for the examination of inner regions
of the liver and PDE + ICG provides a higher-resolution capture
of the outermost regions. The detection of green fluorescence
heralds the presence of neoplastic tissue.
The use of IOUS and PDE in combination can be very useful in
achieving R0 surgery. Surgeons naturally make every attempt to
identify and remove all macroscopically detectable neoplastic
tissue. If there is macroscopic evidence of residual cancer at the
end of surgery, it is generally agreed that the procedure should be
regarded as a technical failure that can be expected to have a
detrimental impact on both disease-free and overall survival. In
most cases, however, this outcome is not the result of a medical
error. Frequently, the disease manifestation is more advanced or
complicated than it appeared on preoperative imaging findings.
This reflects the intrinsic limits of currently available technology.
The surgeon may find an unexpected area of infiltration or a
major blood vessel or bile duct in close proximity to the lesion,
which precludes wider dissection. Because of its infiltrating
nature, the metastatic nodule will be irregularly shaped and thus
the placement of each portion of the resection line potentially
involves making a choice between the risk for immediate organ
damage and the risks associated with a non-radical tumour resec-
tion. In some cases, it is simply impossible to eliminate all nests of
viable cancer cells. In the present group’s experience, NIR imaging
(a) (b)
(c) (d)
Figure 6 The figure is a proof of concept demonstrated by resection specimens and associated images obtained using the Photodynamic
Eye (PDE) with indocyanine green (ICG) staining. (a, b) When PDE + ICG is used to detect large nodules, it allows a safe resection in which
the rim represents the limit of resection. A parenchyma-sparing resection is safer with this technique. (c, d) The PDE + ICG technique is
particularly suited to demonstrating small nodules that may be missed by computed tomography and intraoperative ultrasound. The
technique can be used to change the staging of the disease and possibly the therapeutic approach
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was useful to define the surgical margin. Imaging by NIR was used
not only before, but also after liver resection: in this way, all the
metastatic tissue was removed, with an instant revision of the
resection. In a single case (one of 77), pathology showed an R1
resection. Even in this resection, NIR imaging did not show any
remaining fluorescence, but the section was close to a major vessel
that could not be sacrificed.
The present findings suggest that the use of a combination of
PDE + ICG and IOUS in these settings could increase the accuracy
of intraoperative exploration and dramatically improve the
chances of complete tumour eradication. Further studies will be
necessary to confirm these conclusions in a larger population.
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